Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumors.
Year: 2010
Type: article
Source: PubMed
Authors: Antonella De Luca, Nicola Normanno
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W120231122
